These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22085233)

  • 1. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
    Nguyen PL; Chen MH; Hoffman KE; Chen RC; Hu JC; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV
    BJU Int; 2012 Jul; 110(2):201-5. PubMed ID: 22085233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regret in men treated for localized prostate cancer.
    Hu JC; Kwan L; Saigal CS; Litwin MS
    J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in community practice.
    Hattangadi JA; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    Brachytherapy; 2011; 10(5):369-75. PubMed ID: 21349778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of treatment regret in low-income, uninsured men with prostate cancer.
    Hu JC; Kwan L; Krupski TL; Anger JT; Maliski SL; Connor S; Litwin MS
    Urology; 2008 Dec; 72(6):1274-9. PubMed ID: 18313115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
    J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between race and treatment regret among men with recurrent prostate cancer.
    Mahal BA; Chen MH; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV; Nguyen PL
    Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):38-42. PubMed ID: 25348256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE.
    Mehta SS; Lubeck D; Pasta DJ; Litwin MS
    J Urol; 2003 Nov; 170(5):1931-3. PubMed ID: 14532810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy.
    Nanda A; Chen MH; Moran BJ; Braccioforte MH; Dosoretz D; Salenius S; Katin M; Ross R; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):147-52. PubMed ID: 19744800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.
    Efstathiou JA; Chen MH; Renshaw AA; Loffredo MJ; D'Amico AV
    Cancer; 2007 Apr; 109(8):1493-8. PubMed ID: 17340594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer.
    Hoffman KE; Chen MH; Moran BJ; Braccioforte MH; Dosoretz D; Salenius S; Katin MJ; Ross R; D'Amico AV
    Cancer; 2010 Jun; 116(11):2590-5. PubMed ID: 20310055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy.
    Nanda A; Chen MH; Moran BJ; Braccioforte MH; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e209-15. PubMed ID: 23332383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.
    Dall'Era MA; Cowan JE; Simko J; Shinohara K; Davies B; Konety BR; Meng MV; Perez N; Greene K; Carroll PR
    BJU Int; 2011 Apr; 107(8):1232-7. PubMed ID: 20804478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE.
    Litwin MS; Sadetsky N; Pasta DJ; Lubeck DP
    J Urol; 2004 Aug; 172(2):515-9. PubMed ID: 15247718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of fatigue after treatment for prostate cancer.
    Maliski SL; Kwan L; Orecklin JR; Saigal CS; Litwin MS
    Urology; 2005 Jan; 65(1):101-8. PubMed ID: 15667873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
    Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
    BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.